Foxo technologies™ announces second quarter 2023 financial results

Minneapolis--(business wire)--foxo technologies inc. (nyseam: foxo), a leader in the field of commercializing epigenetic biomarker technology, today reported financial results for the second quarter ended june 30, 2023. “i am very proud of our accomplishments during the second quarter,” said tyler danielson, interim ceo and chief technology officer of foxo. “in addition to streamlining our capital structure, we continued to advance our growth initiatives through product expansion and scientific.
FOXO Ratings Summary
FOXO Quant Ranking